< Back to H.R. 5716 (112th Congress, 2011–2013)

Text of the Melanoma Research Act of 2012

This bill was introduced on May 10, 2012, in a previous session of Congress, but was not enacted. The text of the bill below is as of May 10, 2012 (Introduced).

Download PDF

Source: GPO

I

112th CONGRESS

2d Session

H. R. 5716

IN THE HOUSE OF REPRESENTATIVES

May 10, 2012

(for himself and Mrs. Maloney) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To establish a Skin Cancer Research Fund to increase funding for the conduct or support of research relating to skin cancer by the National Institutes of Health.

1.

Short title

This Act may be cited as the Melanoma Research Act of 2012.

2.

Skin Cancer Research Fund

(a)

Creation of fund

There is established in the Treasury of the United States a trust fund to be known as the Skin Cancer Research Fund, consisting of such amounts as may be deposited into the Skin Cancer Research Fund under subsection (b).

(b)

Transfer to fund of certain amounts

For each of fiscal years 2013 through 2017, there shall be deposited into the Skin Cancer Research Fund amounts equivalent to the taxes received in the Treasury during the respective fiscal year under section 5000B of the Internal Revenue Code of 1986 (26 U.S.C. 5000B; relating to taxes on indoor tanning services).

(c)

Limitation on availability of amounts in fund

Amounts in the Skin Cancer Research Fund shall be available, as provided by appropriation Acts, exclusively for the conduct or support of research relating to skin cancer by the National Institutes of Health under title IV of the Public Health Service Act (42 U.S.C. 281 et seq.).

(d)

Definition

In this Act, the term skin cancer means any of the following:

(1)

Actinic keratosis.

(2)

Basal cell carcinoma.

(3)

Melanoma.

(4)

Kaposi’s sarcoma.

(5)

Squamous cell carcinoma.